Literature DB >> 13898159

[2,2-bis (2-chlorphenyl-4-chlorphenyl)-1,1-dichlorethane] on urinary steroid excretion in persons with normal adrenal glands and in several cases of typical adrenocortex function disorders].

G GEYER, E SCHUELLER.   

Abstract

Entities:  

Keywords:  17-KETOSTEROIDS/urine; ADRENAL CORTEX HORMONES/urine; ADRENAL CORTEX/diseases; DDT/related compounds

Mesh：

Substances：

Year:  1962        PMID： 13898159     DOI： 10.1007/bf01482414

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  15 in total

1.  Excretion of urinary 17-hydroxycorticoids in dogs fed DDD.

Authors:  J H BROWN; J GRIFFIN; R B SMITH
Journal:  Metabolism       Date:  1955-11       Impact factor: 8.694

2.  Biological studies on an adrenocorticolytic agent and the isolation of the active components.

Authors:  C CUETO; J H BROWN; A P RICHARDSON
Journal:  Endocrinology       Date:  1958-03       Impact factor: 4.736

3.  Physiologic activity of an adrenocorticolytic drug in the adult dog.

Authors:  A ANASON; J H BROWN; J B GRIFFIN; R B SMITH
Journal:  Metabolism       Date:  1956-09       Impact factor: 8.694

4.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

5.  Effect of hypophysectomy, DDD treatment, and surgical trauma on the oxygen consumption of the various zones of the adrenal cortex.

Authors:  J NICHOLS; C DAVIS; H D GREEN
Journal:  Endocrinology       Date:  1953-11       Impact factor: 4.736

6.  D.D.D. therapy in Cushing's syndrome.

Authors:  H L SHEEHAN; V K SUMMERS; J NICHOLS
Journal:  Lancet       Date:  1953-02-14       Impact factor: 79.321

7.  Production of insulin sensitivity with the adrenocorticolytic drug DDD (2,2-bis (parachlorophenyl)-1,1-dichloroethane).

Authors:  J NICHOLS; L I GARDNER
Journal:  J Lab Clin Med       Date:  1951-02

8.  The effects of DDD (1, 1-dichloro-2, 2-bis-(p-chlorophenyl)ethane) on the human adrenal; attempts to use an adrenal-destructive agent in the treatment of disseminated mammary and prostatic cancer.

Authors:  H S BLOCH; C R HITCHCOCK; B HOELSCHER; W L WILLIAMS; B ZIMMERMANN
Journal:  Cancer       Date:  1956 Sep-Oct       Impact factor: 6.860

9.  Administration of DDD (2, 2-bis(parachlorophenyl)-1, 1-dichloroethane) to diabetics with hyaline vascular changes and hyperpolysaccharidemia; a preliminary report.

Authors:  N TORNBLOM
Journal:  Acta Med Scand       Date:  1956-03-26

10.  Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(parachlorophenyl)-1,1-dichloroethane (DDD or TDE).

Authors:  A A NELSON; G WOODARD
Journal:  Arch Pathol (Chic)       Date:  1949-11
View more
  2 in total

1.  The effect of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane(o,p'-DDD) on the immune response in malnutrition.

Authors:  J Hamid; A Sayeed; H McFarlane
Journal:  Br J Exp Pathol       Date:  1974-02

2.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.